CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- Open-market buys, last 90 days
- $5,000,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$5,000,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-04 | Hoffman Michael B Director | Shares withheld for taxes | −90 | $19.78 | $2K | 1,416,283 |
| 2022-01-04 | Hoffman Michael B Director | Option exercise · Stock Option (right to buy) | −30,000 | 0 | ||
| 2022-01-04 | Hoffman Michael B Director | Option exercise · Stock Option (right to buy) | −7,142 | 0 | ||
| 2022-01-03 | White Mark K. Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2022-01-03 | McGroarty Jeffrey Brian Chief Financial Officer | Grant or award · Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2022-01-03 | McCarthy Reid Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2022-01-03 | Maccecchini Maria-Luisa President and CEO | Grant or award · Stock Option (right to buy) | +83,400 | 83,400 | ||
| 2022-01-03 | Maccecchini Maria-Luisa President and CEO | Grant or award · Stock Option (right to buy) | +19,894 | 19,894 | ||
| 2022-01-03 | Hoffman Michael B Director | Grant or award · Stock Option (right to buy) | +9,000 | 9,000 | ||
| 2022-01-03 | Bruck Claudine Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2021-12-06 | McGroarty Jeffrey Brian Chief Financial Officer | Grant or award · Stock Option (right to buy) | +30,396 | 30,396 | ||
| 2021-12-06 | McGroarty Jeffrey Brian Chief Financial Officer | Grant or award · Stock Option (right to buy) | +165,199 | 165,199 | ||
| 2021-12-06 | Maccecchini Maria-Luisa President and CEO | Grant or award · Stock Option (right to buy) | +112,995 | 112,995 | ||
| 2021-12-06 | Maccecchini Maria-Luisa President and CEO | Grant or award · Stock Option (right to buy) | +145,305 | 145,305 | ||
| 2021-10-12 | White Mark K. Director | Purchase | +5,000 | $27.40 | $137K | 56,177 |
| 2021-10-11 | Bruck Claudine Director | Purchase | +181 | $27.66 | $5K | 6,067 |
| 2021-10-11 | Maccecchini Maria-Luisa PRESIDENT AND CEO | Purchase | +18,000 | $27.61 | $497K | 976,775 |
| 2021-08-19 | McCarthy Reid Director | Purchase | +500 | $37.61 | $19K | 6,829 |
| 2021-07-07 | White Mark K. Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2021-07-07 | McGroarty Jeffrey Brian Chief Financial Officer | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 |
Page 5 of 8 · 142 trades